The m5C methylation affects the survival risk associated with many tumors, and in hepatocellular carcinoma, high expression of NSUN4 was significantly associated with survival outcomes [22], NSUN4 was also associated with increased risk of breast, ovarian, and prostate cancers [23]. This evidence concerns the gene NSUN4 and prostate carcinoma.